Doddie and Jill are joined by the My Name'5 Doddie Foundation's medical strategy lead Sean McGrath and Professor Ammar Al-Chalabi of King’s College London to discuss clinical trial design, biomarkers, gene therapy and stem cell research, as well as complementary therapies, and there is a real sense of optimism that a cure for MND is closer than we might think. Supported by Aberdeen Standard Investments.
